Since many cancer cells, such as colon and breast cancer, have a defective UPS and elevated proteasome activity, proteasome inhibition in tumor cells has been shown to enhance the accumulation of inhibitors of cyclin-dependent kinases, pro-apoptotic, and tumor suppressor proteins, leading to cell cycle arrest and apoptosis [58,59,60]. Here, TCHP is linked to breast carcinoma.